Illumina, Inc. (ILMN) Stock Analysis
Free AI-powered analysis and research for Illumina, Inc. stock
Sector: Healthcare
Analyze Illumina, Inc. (ILMN) Stock
Illumina, Inc. (ILMN) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into ILMN stock performance, technical indicators, and AI-powered trading recommendations.
Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Illumina, Inc. stock.
Analyze ILMN Now βπ° Latest Update
Illumina upgraded to overweight at JPMorgan on clinical demand outlook
Wed, June 10, 2026 at 7:43 PM UTC 3 min read
Illumina (ILMN) has been upgraded to an "overweight" rating by JPMorgan, reflecting a positive outlook on clinical demand for its genomic sequencing products. This upgrade is significant for investors as it suggests potential growth in revenue driven by increasing adoption of genetic testing in healthcare. As a result, investors may view this as a favorable opportunity to capitalize on Illumina's anticipated market expansion.
History
π Technical Analysis
RSI, MACD, moving averages, support/resistance levels, and momentum indicators for Illumina, Inc. (ILMN) stock.
π€ AI Insights
AI-powered analysis of Illumina, Inc. (ILMN) fundamentals, growth prospects, and market position.
β οΈ Risk Assessment
Comprehensive risk analysis including volatility, sector risks, and market conditions for Illumina, Inc. stock.
Why Analyze Illumina, Inc. (ILMN) with StockIQ?
- β Free AI-powered analysis of Illumina, Inc. (ILMN) stock
- β Real-time technical indicators for Illumina, Inc. stock
- β Comprehensive risk assessment for ILMN
- β No credit card required